Lekha Gupta Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty ICON forecasts 2025 revenue at $8.05 billion–$8.65 billion and adjusted EPS of $13.00 ...

Their quotes aren’t just words; they’re life lessons, battle cries, and celebrations of love and identity. So, let’s take a ...

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries.